1. Section
     LDO StructuredBody (2.16.840.1.113883.2.9.77.1.10.900218)
    1. Section
       Motivo del ricovero (2.16.840.1.113883.2.9.77.1.10.900204)
      1. Entry
         CDA Performer (Body) (2.16.840.1.113883.10.12.323)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      2. Entry
         CDA Author (Body) (2.16.840.1.113883.10.12.318)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        3. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      3. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      4. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    2. Section
       Inquadramento clinico iniziale (2.16.840.1.113883.2.9.77.1.10.900205)
      1. Section
         Anamnesi (2.16.840.1.113883.2.9.77.1.10.900206)
      2. Section
         Esame Obiettivo (2.16.840.1.113883.2.9.77.1.10.900207)
      3. Section
         Terapia Farmacologica all’ingresso (2.16.840.1.113883.2.9.77.1.10.900208)
    3. Section
       Decorso Ospedaliero (2.16.840.1.113883.2.9.77.1.10.900209)
    4. Section
       Riscontri ed accertamenti significativi (2.16.840.1.113883.2.9.77.1.10.900210)
    5. Section
       Procedure eseguite durante il ricovero (2.16.840.1.113883.2.9.77.1.10.900211)
    6. Section
       Allergie (2.16.840.1.113883.2.9.77.1.10.900212)
    7. Section
       Terapia farmacologica effettuata durante il ricovero (2.16.840.1.113883.2.9.77.1.10.900213)
    8. Section
       Condizioni e Diagnosi alla dimissione (2.16.840.1.113883.2.9.77.1.10.900214)
      1. Entry
         CDA Performer (Body) (2.16.840.1.113883.10.12.323)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      2. Entry
         CDA Author (Body) (2.16.840.1.113883.10.12.318)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        3. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      3. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      4. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    9. Section
       Terapia farmacologica alla dimissione (2.16.840.1.113883.2.9.77.1.10.900215)
    10. Section
       Istruzioni di follow-up (2.16.840.1.113883.2.9.77.1.10.900216)